Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q02DX002 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
51.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
39.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
26.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
24.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
9.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
13.0 |
Antitumor endpoint evaluated on day 6; 06/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 6; 02/06 animals surviving on day 6 |
Q02DX002 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 6; 04/06 animals surviving on day 6 |